Bridges Investment Management Has Increased Holding in Buckeye Partners LP Unit LTD (BPL); Pfizer (PFE) Holder Loudon Investment Management Has Lowered Holding by $6.26 Million as Market Valuation Declined

June 23, 2018 - By mmahotstuff

Buckeye Partners, L.P. (NYSE:BPL) Logo

Bridges Investment Management Inc increased its stake in Buckeye Partners LP Unit Ltd (BPL) by 48.18% based on its latest 2018Q1 regulatory filing with the SEC. Bridges Investment Management Inc bought 18,125 shares as the company’s stock declined 22.07% with the market. The institutional investor held 55,742 shares of the natural gas distribution company at the end of 2018Q1, valued at $2.08 million, up from 37,617 at the end of the previous reported quarter. Bridges Investment Management Inc who had been investing in Buckeye Partners LP Unit Ltd for a number of months, seems to be bullish on the $5.56 billion market cap company. The stock increased 0.58% or $0.21 during the last trading session, reaching $36.33. About 746,991 shares traded. Buckeye Partners, L.P. (NYSE:BPL) has declined 45.65% since June 23, 2017 and is downtrending. It has underperformed by 58.22% the S&P500. Some Historical BPL News: 06/03/2018 – Buckeye Partners, L.P.’s 2017 Schedule K-1 Tax Packages Are Now Available; 23/03/2018 – BUCKEYE PARTNERS LP BPL.N : MORGAN STANLEY CUTS TO EQUAL-WEIGHT FROM OVERWEIGHT; 13/04/2018 – Tribune 242: Shell Deal To Help `Revolutionise’ Bpl; 23/04/2018 – DJ Buckeye Partners LP, Inst Holders, 1Q 2018 (BPL); 04/05/2018 – Buckeye Partners 1Q Rev $1.18B; 04/05/2018 – BUCKEYE PARTNERS LP – QTRLY TOTAL REVENUE $1,183.1 MLN VS $969.3 MLN; 06/04/2018 – BUCKEYE PARTNERS- ACTIVELY UNDERTAKING STEPS NECESSARY TO PROVIDE Bl-DIRECTIONAL SERVICE TO PITTSBURGH SECTION OF REFINED FUELS PIPELINE SYSTEM; 05/04/2018 – Buckeye Announces Expansion of Chicago Complex and Execution of Long-Term Agreement With BP; 06/04/2018 – Buckeye Partners to Move Forward With Bi-Directional Laurel Service; Operational Solution Will Enhance Market Competition; 04/05/2018 – BUCKEYE PARTNERS 1Q EPS CONT OPS 74C, EST. 81C

Loudon Investment Management Llc decreased its stake in Pfizer Inc (PFE) by 78.74% based on its latest 2018Q1 regulatory filing with the SEC. Loudon Investment Management Llc sold 54,887 shares as the company’s stock declined 3.80% with the market. The institutional investor held 14,820 shares of the health care company at the end of 2018Q1, valued at $1.70 million, down from 69,707 at the end of the previous reported quarter. Loudon Investment Management Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $213.57B market cap company. The stock increased 0.58% or $0.21 during the last trading session, reaching $36.51. About 26.61M shares traded or 24.93% up from the average. Pfizer Inc. (NYSE:PFE) has risen 10.95% since June 23, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 23/03/2018 – PFIZER CONTINUES TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVES; 23/03/2018 – GSK’s two-drug HIV regimen wins European panel approval; 23/03/2018 – PFIZER: CHANTIX/CHAMPIX STUDY DID NOT MEET PRIMARY ENDPOINT; 16/04/2018 – BRISTOL-MYERS SQUIBB – IN PHASE 3 CHECKMATE -214 TRIAL, OPDIVO + YERVOY ALSO DELIVERED DURABLE RESPONSES, WITH HIGHER OBJECTIVE RESPONSE RATE VS SUNITINIB; 29/05/2018 – Phase lll lMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to; 21/03/2018 – Britain’s use of copycat biotech drugs takes off while U.S. lags; 21/03/2018 – Reckitt ends pursuit for part of Pfizer’s consumer healthcare unit; 22/03/2018 – GSK in pole position to clinch Pfizer assets; 21/03/2018 – RECKITT BENCKISER – ACQUISITION FOR WHOLE PFIZER CONSUMER HEALTH BUSINESS DID NOT FIT ACQUISITION CRITERIA, ACQUISITION OF PART OF BUSINESS WAS NOT POSSIBLE; 03/04/2018 – PFIZER AND ALLOGENE THERAPEUTICS ENTER INTO ASSET CONTRIBUTION AGREEMENT FOR PFIZER’S ALLOGENEIC CAR T IMMUNO-ONCOLOGY PORTFOLIO

Since February 24, 2018, it had 0 insider buys, and 13 selling transactions for $18.09 million activity. $501,398 worth of Pfizer Inc. (NYSE:PFE) shares were sold by Dolsten Mikael. OLSON LAURIE J sold $692,582 worth of Pfizer Inc. (NYSE:PFE) on Wednesday, June 6. 9,510 shares valued at $353,677 were sold by LUND-JURGENSEN KIRSTEN on Saturday, February 24. SUSMAN SALLY had sold 33,368 shares worth $1.24 million. LANKLER DOUGLAS M also sold $1.84 million worth of Pfizer Inc. (NYSE:PFE) on Tuesday, March 13. 27,323 shares were sold by JOHNSON RADY A, worth $998,666.

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It worsened, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Forward Mngmt Ltd Liability Com invested 0.18% in Pfizer Inc. (NYSE:PFE). Seizert Capital Prtnrs Ltd Liability holds 0.57% of its portfolio in Pfizer Inc. (NYSE:PFE) for 441,272 shares. Arizona-based Tci Wealth Advsr has invested 1.15% in Pfizer Inc. (NYSE:PFE). Kemnay Advisory Svcs Inc stated it has 1,500 shares. Barry Inv Advisors Ltd Liability holds 3.9% of its portfolio in Pfizer Inc. (NYSE:PFE) for 289,663 shares. Adell Harriman Carpenter Incorporated holds 0% or 174,651 shares in its portfolio. Thrivent For Lutherans has invested 0.5% of its portfolio in Pfizer Inc. (NYSE:PFE). Verity & Verity Ltd Liability Co owns 225,751 shares or 2.16% of their US portfolio. Barclays Public Ltd Liability Corp holds 13.37M shares or 0.36% of its portfolio. Aviva Public Ltd Co stated it has 4.83 million shares or 1.05% of all its holdings. Blackhill Cap reported 3.09% of its portfolio in Pfizer Inc. (NYSE:PFE). Tsp Capital Mgmt Group Ltd Company reported 57,777 shares or 0.98% of all its holdings. Rhenman And Prns Asset Ab has invested 0.04% in Pfizer Inc. (NYSE:PFE). 693,818 are owned by Fishman Jay A Mi. Horan Capital Mgmt accumulated 251,631 shares.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Investorplace.com which released: “3 Big Stock Charts for Thursday: JPMorgan Chase, Pfizer and Disney” on June 21, 2018, also Fool.com with their article: “Better Buy: Pfizer Inc. vs. Johnson & Johnson” published on June 17, 2018, Bizjournals.com published: “In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection” on June 07, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Fool.com and their article: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” published on June 20, 2018 as well as Seekingalpha.com‘s news article titled: “Pfizer – Still A Hold For The Dividend” with publication date: June 08, 2018.

Loudon Investment Management Llc, which manages about $170.56M and $127.24M US Long portfolio, upped its stake in Paychex Inc (NASDAQ:PAYX) by 9,062 shares to 12,946 shares, valued at $1.41 million in 2018Q1, according to the filing. It also increased its holding in Aflac Inc (NYSE:AFL) by 31,210 shares in the quarter, for a total of 63,480 shares, and has risen its stake in Spdr Series Trust (SDY).

Among 23 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Pfizer had 80 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, April 28 by BMO Capital Markets. Jefferies maintained Pfizer Inc. (NYSE:PFE) on Monday, February 26 with “Hold” rating. S&P Research maintained it with “Hold” rating and $40 target in Wednesday, October 28 report. The rating was maintained by Jefferies on Tuesday, September 13 with “Buy”. As per Tuesday, September 5, the company rating was maintained by BMO Capital Markets. The firm earned “Buy” rating on Tuesday, June 14 by Jefferies. The firm has “Overweight” rating given on Tuesday, November 29 by Barclays Capital. The company was maintained on Monday, September 18 by Cowen & Co. Credit Suisse maintained Pfizer Inc. (NYSE:PFE) rating on Monday, May 9. Credit Suisse has “Outperform” rating and $39 target. The stock has “Overweight” rating by JP Morgan on Thursday, April 7.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 earnings per share, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39B for 12.17 P/E if the $0.75 EPS becomes a reality. After $0.77 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Since March 9, 2018, it had 1 insider buy, and 2 selling transactions for $874,624 activity. 11,300 shares were sold by RUSSO TODD J, worth $429,380 on Tuesday, May 22. Another trade for 11,013 shares valued at $483,707 was sold by Sauger Joseph.

More notable recent Buckeye Partners, L.P. (NYSE:BPL) news were published by: Nasdaq.com which released: “Report: Developing Opportunities within HealthEquity, Sonic, FLIR, Nustar GP, Ashland Global, and Buckeye Partners …” on June 19, 2018, also Fool.com with their article: “Why I Chose to Buy This High-Yield Dividend Stock” published on June 06, 2018, Seekingalpha.com published: “Why Buckeye Partners’ Sales Growth Is Misleading” on June 06, 2018. More interesting news about Buckeye Partners, L.P. (NYSE:BPL) were released by: Bizjournals.com and their article: “Exxon Mobil, Plains All American to create Permian pipeline JV” published on June 13, 2018 as well as Seekingalpha.com‘s news article titled: “Buckeye Partners: Follow Cash Flow From Operations” with publication date: May 31, 2018.

Among 18 analysts covering Buckeye Partners (NYSE:BPL), 3 have Buy rating, 1 Sell and 14 Hold. Therefore 17% are positive. Buckeye Partners had 63 analyst reports since August 4, 2015 according to SRatingsIntel. Barclays Capital reinitiated it with “Equal Weight” rating and $72 target in Tuesday, January 17 report. Bank of America maintained it with “Neutral” rating and $52 target in Tuesday, March 6 report. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, July 13. The firm earned “Neutral” rating on Tuesday, March 13 by JP Morgan. The rating was maintained by SunTrust on Sunday, April 22 with “Hold”. The rating was maintained by Citigroup on Tuesday, March 27 with “Buy”. DA Davidson initiated Buckeye Partners, L.P. (NYSE:BPL) on Monday, November 16 with “Neutral” rating. The rating was downgraded by UBS on Tuesday, June 12 to “Hold”. The company was maintained on Monday, November 7 by Mizuho. The company was maintained on Monday, November 6 by Barclays Capital.

Bridges Investment Management Inc, which manages about $695.30 million and $2.17B US Long portfolio, decreased its stake in T Rowe Price Group Inc (NASDAQ:TROW) by 11,123 shares to 14,365 shares, valued at $1.55M in 2018Q1, according to the filing.

Investors sentiment increased to 0.79 in Q1 2018. Its up 0.22, from 0.57 in 2017Q4. It improved, as 56 investors sold BPL shares while 70 reduced holdings. 24 funds opened positions while 76 raised stakes. 99.68 million shares or 1.01% more from 98.68 million shares in 2017Q4 were reported. Barnett accumulated 14,475 shares. Moreover, Signaturefd Limited Liability Company has 0.04% invested in Buckeye Partners, L.P. (NYSE:BPL). Loring Wolcott Coolidge Fiduciary Llp Ma has invested 0% in Buckeye Partners, L.P. (NYSE:BPL). Ancora Advsr Limited Liability accumulated 14,568 shares. Fifth Third Savings Bank holds 0% of its portfolio in Buckeye Partners, L.P. (NYSE:BPL) for 4,260 shares. Clinton Gru owns 6,803 shares. Benjamin F Edwards And Com reported 0% of its portfolio in Buckeye Partners, L.P. (NYSE:BPL). Ballentine Prtnrs Llc reported 0.06% in Buckeye Partners, L.P. (NYSE:BPL). Moreover, Miller Howard New York has 0.39% invested in Buckeye Partners, L.P. (NYSE:BPL) for 440,259 shares. 993,959 are owned by Creative Planning. Peak6 Invests LP invested in 30,279 shares or 0% of the stock. 13,757 were accumulated by Cambridge Advsr. Deutsche Natl Bank Ag has invested 0.03% in Buckeye Partners, L.P. (NYSE:BPL). Mariner Ltd Company accumulated 44,428 shares or 0.06% of the stock. 1,000 were accumulated by Duncker Streett.

Buckeye Partners, L.P. (NYSE:BPL) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>